Alina Dufek is an accomplished finance and investment professional with extensive experience in private equity, gene editing therapeutics, and quantitative research. Currently serving in PEWIN, a network fostering senior women in private equity since 2020, Alina also holds a position as an investor in Excision BioTherapeutics, contributing to its Series B funding efforts. Previous roles include Financial Representative at Modern Woodmen of America, Chief Investment Officer at Virgil Quantitative Research, Portfolio Manager at Fayette Capital, and Equity Derivatives Trader at Charles Schwab. Alina holds an MBA from Columbia Business School and a bachelor's degree from Université Paris-Saclay, further enhanced by a program at the Massachusetts Institute of Technology.
This person is not in any teams
This person is not in any offices